(Q28382120)

English

EGFR Copy Number Variation

genetic variant

COPY NUMBER VARIATION

In more languages

Statements

Copy Number Change

1 reference

25 February 2022

https://civic.genome.wustl.edu/links/variants/191

human chromosome 7

genomic assembly

Genome assembly GRCh37

1 reference

25 February 2022

https://civic.genome.wustl.edu/links/variants/191

55086794

genomic assembly

Genome assembly GRCh37

1 reference

25 February 2022

https://civic.genome.wustl.edu/links/variants/191

55279321

genomic assembly

Genome assembly GRCh37

1 reference

25 February 2022

https://civic.genome.wustl.edu/links/variants/191

biological variant of

1 reference

25 February 2022

https://civic.genome.wustl.edu/links/variants/191

positive therapeutic predictor for

determination method

CIViC evidence level B

CIViC 4-star trust rating

medical condition treated

non-small-cell lung carcinoma

2 references

22 January 2021

https://civic.genome.wustl.edu/links/evidence/5924

EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer

22 January 2021

https://civic.genome.wustl.edu/links/evidence/5925

EGFR gene copy number as a predictive/biomarker for patients with non-small-cell lung cancer receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis

determination method

CIViC evidence level B

CIViC 4-star trust rating

medical condition treated

non-small-cell lung carcinoma

2 references

22 January 2021

https://civic.genome.wustl.edu/links/evidence/5924

EGFR gene copy number as a predictive biomarker for patients receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis in non-small-cell lung cancer

22 January 2021

https://civic.genome.wustl.edu/links/evidence/5925

EGFR gene copy number as a predictive/biomarker for patients with non-small-cell lung cancer receiving tyrosine kinase inhibitor treatment: a systematic review and meta-analysis

negative prognostic predictor for

head and neck squamous cell carcinoma

determination method

CIViC evidence level B

CIViC 4-star trust rating

1 reference

25 February 2022

https://civic.genome.wustl.edu/links/evidence/472

Epidermal growth factor receptor copy number alterations correlate with poor clinical outcome in patients with head and neck squamous cancer

Identifiers

CIViC variant ID

1 reference

25 February 2022

https://civic.genome.wustl.edu/links/variants/191

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q28382120&oldid=2014800631"